KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a Multicenter, Randomized, Phase 2b/3 Clinical Trial.Influenza Other Respir VirusesPMID 38890511PMC111879112024-Jun0.98未发现恶性肿瘤人群证据。待处理
Avelumab first-line maintenance in advanced urothelial carcinoma: Complete screening for prognostic and predictive factors using machine learning in the JAVELIN Bladder 100 phase 3 trial.Cancer MedPMID 38924353PMC111946832024-Jun0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme.J Crohns ColitisPMID 37942921PMC111406242024-May-310.98未发现恶性肿瘤人群证据。待处理
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy.N Engl J MedPMID 38739079无 PMCID2024-May-300.98未发现恶性肿瘤人群证据。待处理
Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.Mol CancerPMID 38811992PMC111379562024-May-300.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency.Blood AdvPMID 38330179PMC111126042024-May-280.98未发现恶性肿瘤人群证据。待处理
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.JAMAPMID 38683596PMC110590552024-May-280.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study.RMD OpenPMID 38806190PMC111382712024-May-280.95The study fails the oncology criterion as it is not a cancer trial. It also lacks the required time-to-event efficacy endpoint (e.g., OS, PFS, DFS, EFS, RFS, TTP, or a Kaplan-Meier/HR analysis of such).待处理
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.BMJPMID 38806195无 PMCID2024-May-280.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.LancetPMID 38705160无 PMCID2024-May-250.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Rose geranium in sesame oil nasal spray to improve nasal vestibulitis symptoms: a randomized controlled trial.Support Care CancerPMID 38789656无 PMCID2024-May-240.98未发现恶性肿瘤人群证据。待处理
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer.BMC CancerPMID 38789924PMC111274592024-May-240.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis.Arthritis Res TherPMID 38790040PMC111272902024-May-240.98未发现恶性肿瘤人群证据。待处理
Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER.Br J OphthalmolPMID 37669850PMC111374412024-May-210.98未发现恶性肿瘤人群证据。待处理
Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study.J Med GenetPMID 37940383PMC111374422024-May-210.98未发现恶性肿瘤人群证据。待处理
High-precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION trial).TrialsPMID 38773643PMC111068732024-May-210.98未发现恶性肿瘤人群证据。待处理
Tildrakizumab for moderate-to-severe plaque psoriasis in Chinese patients: A 12-week randomized placebo-controlled phase III trial with long-term extension.Chin Med J (Engl)PMID 38192233PMC111012242024-May-200.98未发现恶性肿瘤人群证据。待处理
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial.J Clin OncolPMID 38412399无 PMCID2024-May-200.95The study is a Phase III randomized trial in oncology patients with a drug intervention and an original result. However, it is ineligible because the primary endpoint (incidence of hand-foot syndrome) is a safety/tolerability outcome, not a time-to-event efficacy endpoint as required (e.g., OS, PFS, DFS, EFS, RFS, TTP, Kaplan-Meier, or HR).待处理
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression.J Clin OncolPMID 38422473PMC111078942024-May-200.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials.Br J DermatolPMID 38470171无 PMCID2024-May-170.98未发现恶性肿瘤人群证据。待处理
MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231.BloodPMID 38457359PMC111435152024-May-160.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.N Engl J MedPMID 38587247无 PMCID2024-May-160.98未发现恶性肿瘤人群证据。待处理
Perioperative Nivolumab in Resectable Lung Cancer.N Engl J MedPMID 38749033无 PMCID2024-May-160.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults.Clin Infect DisPMID 37992000PMC110936692024-May-150.98未发现恶性肿瘤人群证据。待处理
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds.Clin Infect DisPMID 38016021PMC110936712024-May-150.98未发现恶性肿瘤人群证据。待处理
Evolution of atrophied T2 lesion volume in primary-progressive multiple sclerosis: results from the phase 3 ORATORIO study.J Neurol Neurosurg PsychiatryPMID 38071574无 PMCID2024-May-140.98未发现恶性肿瘤人群证据。待处理
Horwitz SM, Scarisbrick JJ, Dummer R, et al. Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data. Blood Adv. 2021;5(23):5098-5106.Blood AdvPMID 38743412PMC111169952024-May-140.45Title and metadata indicate a randomized Phase III oncology trial with a drug intervention, but the abstract is not provided and no time-to-event signal (OS, PFS, DFS, HR, Kaplan-Meier) is detected in the provided metadata. Cannot confirm human subjects or that this is an original result report (vs. update, erratum, etc.).待处理
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials.Nat CommunPMID 38744844PMC110940492024-May-140.98未发现恶性肿瘤人群证据。待处理
Herbal medicine for the prevention of chemotherapy-induced nausea and vomiting in patients with advanced colorectal cancer: A prospective randomized controlled trial.J EthnopharmacolPMID 38341113无 PMCID2024-May-100.90The trial is a randomized Phase III study in oncology patients with a drug intervention and reports original results. However, it is not eligible for the cohort because the primary and secondary endpoints are categorical response rates for chemotherapy-induced nausea and vomiting and quality-of-life scores, which are not time-to-event efficacy endpoints (e.g., OS, PFS, DFS). The study lacks any Kaplan-Meier analysis, hazard ratio, or other time-to-event outcome.待处理
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.J Clin OncolPMID 38364196无 PMCID2024-May-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Pembrolizumab Versus Placebo as Adjuvant Therapy in Resected Stage IIB or IIC Melanoma: Final Analysis of Distant Metastasis-Free Survival in the Phase III KEYNOTE-716 Study.J Clin OncolPMID 38452313PMC110958692024-May-100.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18-49 years of age: Results of a randomized phase 3 study.VaccinePMID 38616438无 PMCID2024-May-100.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and safety of a 14-valent pneumococcal polysaccharide conjugate vaccine (PNEUBEVAX 14™) administered to 6-8 weeks old healthy Indian Infants: A single blind, randomized, active-controlled, Phase-III study.VaccinePMID 38637211无 PMCID2024-May-100.98未发现恶性肿瘤人群证据。待处理
Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.Alzheimers Res TherPMID 38730496PMC110840612024-May-100.98未发现恶性肿瘤人群证据。待处理
Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status.RMD OpenPMID 38724259PMC110864262024-May-090.98未发现恶性肿瘤人群证据。待处理
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial.Signal Transduct Target TherPMID 38705885PMC110704142024-May-060.95The study is a Phase III randomized oncology trial with a primary time-to-event endpoint (OS) and original results, but the intervention is a transplant procedure (haploidentical and cord blood HCT) and does not involve a drug-containing intervention as defined by the adjudication rules.待处理
RNA Polymerase Inhibitor Enisamium for Treatment of Moderate COVID-19 Patients: A Randomized, Placebo-Controlled, Multicenter, Double-Blind Phase 3 Clinical Trial.Adv Respir MedPMID 38804439PMC111309362024-May-060.98未发现恶性肿瘤人群证据。待处理
Evaluating the heterogeneity of hippocampal avoidant whole brain radiotherapy treatment effect: A secondary analysis of NRG CC001.Neuro OncolPMID 38069666PMC110669392024-May-030.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma.Neuro OncolPMID 38445964PMC110669382024-May-030.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Population pharmacokinetic modeling of dolutegravir/lamivudine to support a once-daily fixed-dose combination regimen in virologically suppressed adults living with HIV-1.Antimicrob Agents ChemotherPMID 38587380PMC110645442024-May-020.98未发现恶性肿瘤人群证据。待处理
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.N Engl J MedPMID 38692292无 PMCID2024-May-020.98未发现恶性肿瘤人群证据。待处理
Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial.Int J Radiat Oncol Biol PhysPMID 37924987PMC110237962024-May-010.85The record is a secondary analysis of a Phase III RCT in oncology (prostate cancer) but does not report any of the required efficacy outcomes (survival, progression, recurrence, death, hazard, time-to-event). It reports on bone mineral density and fracture, which are not considered primary oncology efficacy outcomes for this adjudication.待处理
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial.J Clin OncolPMID 38315944无 PMCID2024-May-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China.DiabetesPMID 38320260PMC110430582024-May-010.98未发现恶性肿瘤人群证据。待处理
Improved Disease-Free Survival With Adjuvant Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Cancer: Final Results of the POUT Trial.J Clin OncolPMID 38350047PMC110958772024-May-010.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial.Am J Respir Crit Care MedPMID 38354066PMC110929572024-May-010.98未发现恶性肿瘤人群证据。待处理
Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS).J Affect DisordPMID 38378088无 PMCID2024-May-010.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer.JAMA OncolPMID 38451492PMC109213492024-May-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial.JAMA OncolPMID 38483412PMC109410192024-May-010.95The trial is a Phase III randomized clinical trial in oncology with a primary patient-reported outcome endpoint and secondary time-to-event endpoints. However, the intervention is radiotherapy (a non-drug therapy), and no drug-containing intervention is described. Eligibility requires a drug-containing intervention, so the record is excluded.待处理
Ventilatory Assistance Before Umbilical Cord Clamping in Extremely Preterm Infants: A Randomized Clinical Trial.JAMA Netw OpenPMID 38758557PMC111020172024-May-010.98未发现恶性肿瘤人群证据。待处理